The Food and Drug Administration yesterday warned health care providers and consumers that certain hand sanitizers have tested positive for 1-propanol, including products made by Harmonic Nature S de RL de MI in Mexico.

“1-propanol, not to be confused with 2-propanol/isopropanol/isopropyl alcohol, is not an acceptable ingredient for hand sanitizer products marketed in the United States and can be toxic and life-threatening when ingested,” FDA said.

The agency has expanded its list of do-not-use hand sanitizers to include products that contain or may contain this ingredient, and encourages providers and others to report adverse events or quality problems associated with hand sanitizers to its MedWatch program.

In other news, FDA recently approved for marketing in the U.S. a surgical gown (K200977) and three polymer patient examination gloves (K201530, K201531, K193666), including for use during the COVID-19 pandemic. In addition, the agency authorized for emergency use molecular tests made by LumiraDx UK Ltd. and Biomeme Inc. to detect SARS-CoV-2. Laboratories certified to perform high-complexity tests under the Clinical Laboratory Improvement Amendments of 1988 may use the tests.

Headline
There are now 17,180 confirmed cases of cyclosporiasis in the U.S., the Centers for Disease Control and Prevention reported Aug. 25. At least 11,844 additional…
Headline
The Food and Drug Administration has approved a blood test for detecting Alzheimer’s by Roche and Eli Lilly, according to an announcement Aug. 24 by Roche. The…
Headline
There have been 15,716 confirmed cases of cyclosporiasis across 47 states, Washington, D.C., and Puerto Rico since May 1, the Centers for Disease Control and…
Blog
By Rani E. Snyder, President, The John A. Hartford Foundation and Dr. Chris DeRienzo, AHA Chief Physician Executive/President of AHA’s HRET As the U.S.…
Headline
The Department of Health and Human Services Aug. 14 announced that three health systems have signed the agency’s voluntary pledge related to hospital efforts…
Headline
The Centers for Disease Control and Prevention Aug. 11 released a health advisory on the risk of severe arboviral disease among patients receiving B-cell-…